Treatment Resistant Depression Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Treatment Resistant Depression stocks.

Treatment Resistant Depression Stocks Recent News

Date Stock Title
Dec 3 LLY J&J Seeks FDA Approval for Tremfya for Psoriasis in Kids
Dec 3 LLY Exclusive-Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Dec 2 LLY Four oral GLP-1R products in Phase III trials as race intensifies
Dec 2 LLY Diabetes advocacy group discourages use of compounded GLP-1 drugs
Dec 2 LLY Why Is Eli Lilly and Company (LLY) Among Ken Fisher’s Top Stock Picks Heading Into 2025?
Dec 2 LLY Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study
Dec 1 LLY Why Is Eli Lilly and Company (LLY) Among Louis Navellier’s Top Stock Picks Heading Into 2025?
Nov 30 LLY Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger
Nov 30 CMPS Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
Nov 29 LLY The Score: GM, Macy’s, Novo Nordisk and More Stocks That Defined the Week
Nov 29 LLY Galderma Bets on Skin Drug to Turn Around Pharma Business
Nov 29 LLY Why Is Lilly (LLY) Down 5% Since Last Earnings Report?
Nov 29 AXSM Axsome: Focus On AXS-12 Targeting Narcolepsy, Which Just Released Positive Data
Nov 29 LLY Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Nov 29 LLY Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
Nov 29 LLY Radiopharmaceutical trials face extra complexities due to nuclear red tape
Nov 28 LLY EC Approves NVS' Kisqali for a Broad Population in Early Breast Cancer
Nov 28 LLY Eli Lilly: An Early Christmas Present Has Just Arrived (Rating Upgrade)
Nov 28 LLY Down More Than 20% From Its High, Is Now the Time to Buy Eli Lilly Stock?
Nov 27 AXSM Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says
Treatment Resistant Depression

Treatment Resistant Depression (TRD) is a type of depression that does not respond to traditional treatments such as antidepressant medications, psychotherapy, or other forms of therapy. People with TRD may experience symptoms such as persistent sadness, loss of interest in activities, difficulty concentrating, fatigue, and changes in appetite and sleep. Treatment options for TRD may include medications, electroconvulsive therapy, transcranial magnetic stimulation, and other forms of therapy.

Browse All Tags